Abstract:Background. At least 55 million individuals suffer from dementia globally, of which Alzheimer's disease (AD) accounts for 60-70% of cases. Alzheimer's disease is the only major cause of death that is still growing. However, the molecular mechanisms are largely unknown in the progress of AD. Objectives. The goal of the study was to assess whether lncRNA brain-derived neurotrophic factor antisense (BDNF-AS) could affect processes underlying the regulation of neuronal cell apoptosis in rat and cellular models of AD by directing the expression of miR-125b-5p. Materials and methods. The amyloid-ss (A ss)(1-42)-induced rat and cellular models of AD were established. Changes in learning and memory in rats were detected with the use of the Morris water maze. Cell viability and apoptosis were determined using the 3-(4,5- dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT) test and flow cytometry. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was applied to detect the expression of lncRNA BDNF-AS and miR-125b-5p, and western blotting was utilized to examine proteins. The correlations between lncRNA BDNF-AS and miR-125b-5p were demonstrated using dual-luciferase reporter gene assays. Results. Our results showed that BDNF-AS was upregulated and miR-125b-5p was downregulated in the rat and cellular AD models. The addition of si- BDNF-AS and miR-125b-5p mimics shortened the escape latency and swimming distance in the rat model. Furthermore, the knockdown of BDNF-AS or the administration of miR-125b-5p mimic significantly suppressed cell apoptosis, cell inflammatory, and inflammatory pathwayrelated proteins, while these cellular activities were promoted in rat and cellular models of AD. Additionally, miR-125b-5p was found to be a BDNF-AS target gene that was linked negatively with BDNF-AS in AD. Conclusions. Through regulation of miR-125b-5p, lncRNA BDNF-AS suppressed cell death, inflammation and inflammatory pathway-related proteins in AD models, which provides a potential biomarker and therapeutic target in the clinical treatment of AD.

BACE1-AS Prevents BACE1 Mrna Degradation Through the Sequestration of BACE1-targeting Mirnas.

The Effect of BACE1-AS on Β-Amyloid Generation by Regulating BACE1 Mrna Expression

LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease

LncRNA BDNF-AS as ceRNA regulates the miR-9-5p/BACE1 pathway affecting neurotoxicity in Alzheimer's disease

miR-15b represses BACE1 expression in sporadic Alzheimer's disease.

Mir-124 Downregulates Bace 1 and Alters Autophagy in App/Ps1 Transgenic Mice

BAG-1M Co-Activates BACE1 Transcription Through NF-κB and Accelerates Aβ Production and Memory Deficit in Alzheimer's Disease Mouse Model.

BACE1 SUMOylation Increases Its Stability and Escalates the Protease Activity in Alzheimer's Disease.

Long Non-Coding RNA BACE1-AS Modulates Isoflurane-Induced Neurotoxicity to Alzheimer’s Disease Through Sponging miR-214-3p

BACE1 controls synaptic function through modulating release of synaptic vesicles

EPB41L4A-AS1 modulates Aβ clearance by regulating autophagy-related gene expression

The Long Non-Coding RNA BDNF-AS Induces Neuronal Cell Apoptosis by Targeting Mir-125B-5p in Alzheimer's Disease Models.

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

The Mir-124 Regulates the Expression of BACE1/β-secretase Correlated with Cell Death in Alzheimer's Disease.

The Mir-124 Regulates The Expression Of Bace1/Beta-Secretase Correlated With Cell Death In Alzheimer'S Disease

EPB41L4A-AS1 is Required to Maintain Basal Autophagy to Modulates Aβ Clearance

BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides

MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects

M1 Muscarinic Acetylcholine Receptor Interacts with BACE1 and Regulates Its Proteosomal Degradation.

Distinct Transcriptional Regulation and Function of the Human Bace2 and Bace1 Genes

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)